Today Kedrion Biopharma announced the nationwide commercial availability of QIVIGY, its FDA‑approved 10% Intravenous Immunoglobulin (IVIG) therapy, through a broad U.S. distribution model designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results